Obatoclax is an experimental drug candidate for the treatment of various types of cancer. It was discovered by Gemin X which was acquired by Cephalon. It is in Phase II clinical trials for the treatment of leukemia lymphoma myelofibrosis and mastocytosis.
This page contains content from the copyrighted Wikipedia article "Obatoclax"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
